Niagen Bioscience (NAGE) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $2.49, -3.49% vs the prior close of $2.58.
- Volume 555.77K shares, 1.1x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
NAGE slides 3.5% to $2.49, a 52-week low. Closed at $2.49, -3.49% vs the prior close of $2.58. Day range $2.46–$2.59, opened at $2.58.
NAGE daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — NAGE slides 3.5% to $2.49, a 52-week low
- Closed at $2.49, -3.49% vs the prior close of $2.58. Day range $2.46–$2.59, opened at $2.58.
- Volume was 555.77K shares, 1.1x its 50-day average of 493.79K.
- Price is -16.4% vs its 50-day average ($2.98) and -39.5% vs its 200-day average ($4.12).
- 52-week range $2.46–$7.95; today's close sits at 1% of that range, 68.7% below the 52-week high.
Oct 15, 2026 — NAGE rises 2.0% to $2.58
- Closed at $2.58, +1.98% vs the prior close of $2.53. Day range $2.53–$2.60, opened at $2.55.
- Volume was 444.20K shares, 0.9x its 50-day average of 521.43K.
- Price is -13.7% vs its 50-day average ($2.99) and -37.6% vs its 200-day average ($4.14).
- 52-week range $2.51–$7.95; today's close sits at 1% of that range, 67.5% below the 52-week high.
Oct 14, 2026 — NAGE dips 1.9% to $2.53, a 52-week low, 3 down days in a row
- Closed at $2.53, -1.94% vs the prior close of $2.58. Day range $2.51–$2.59, opened at $2.55.
- Volume was 522.90K shares, 1.0x its 50-day average of 531.57K.
- Price is -15.6% vs its 50-day average ($3.00) and -39.1% vs its 200-day average ($4.16).
- 52-week range $2.51–$7.95; today's close sits at 0% of that range, 68.2% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — NAGE dips 1.9% to $2.58, a 52-week low
- Closed at $2.58, -1.90% vs the prior close of $2.63. Day range $2.55–$2.64, opened at $2.63.
- Volume was 636.50K shares, 1.2x its 50-day average of 544.12K.
- Price is -14.5% vs its 50-day average ($3.02) and -38.2% vs its 200-day average ($4.18).
- 52-week range $2.55–$7.95; today's close sits at 1% of that range, 67.5% below the 52-week high.
Oct 12, 2026 — NAGE dips 2.2% to $2.63, a 52-week low
- Closed at $2.63, -2.23% vs the prior close of $2.69. Day range $2.60–$2.68, opened at $2.67.
- Volume was 407.80K shares, 0.7x its 50-day average of 548.93K.
- Price is -13.4% vs its 50-day average ($3.04) and -37.3% vs its 200-day average ($4.20).
- 52-week range $2.60–$7.95; today's close sits at 1% of that range, 66.9% below the 52-week high.
Oct 9, 2026 — NAGE rises 1.1% to $2.69
- Closed at $2.69, +1.13% vs the prior close of $2.66. Day range $2.67–$2.71, opened at $2.68.
- Volume was 268.10K shares, 0.5x its 50-day average of 555.07K — lighter than usual.
- Price is -11.9% vs its 50-day average ($3.05) and -36.2% vs its 200-day average ($4.22).
- 52-week range $2.61–$7.95; today's close sits at 1% of that range, 66.2% below the 52-week high.
Oct 8, 2026 — NAGE dips 2.2% to $2.66, a 52-week low
- Closed at $2.66, -2.21% vs the prior close of $2.72. Day range $2.61–$2.71, opened at $2.71.
- Volume was 635.10K shares, 1.1x its 50-day average of 558.60K.
- Price is -13.2% vs its 50-day average ($3.06) and -37.2% vs its 200-day average ($4.24).
- 52-week range $2.61–$7.95; today's close sits at 1% of that range, 66.5% below the 52-week high.
Oct 7, 2026 — NAGE rises 1.1% to $2.72
- Closed at $2.72, +1.12% vs the prior close of $2.69. Day range $2.65–$2.76, opened at $2.67.
- Volume was 361.10K shares, 0.6x its 50-day average of 561.74K.
- Price is -11.6% vs its 50-day average ($3.08) and -36.1% vs its 200-day average ($4.26).
- 52-week range $2.61–$7.95; today's close sits at 2% of that range, 65.8% below the 52-week high.
Oct 6, 2026 — NAGE rises 0.4% to $2.69
- Closed at $2.69, +0.37% vs the prior close of $2.68. Day range $2.66–$2.71, opened at $2.67.
- Volume was 373.20K shares, 0.7x its 50-day average of 562.54K.
- Price is -12.9% vs its 50-day average ($3.09) and -37.1% vs its 200-day average ($4.27).
- 52-week range $2.61–$7.95; today's close sits at 1% of that range, 66.2% below the 52-week high.
Oct 5, 2026 — NAGE slides 3.9% to $2.68
- Closed at $2.68, -3.94% vs the prior close of $2.79. Day range $2.67–$2.79, opened at $2.79.
- Volume was 864.80K shares, 1.6x its 50-day average of 554.50K.
- Price is -13.5% vs its 50-day average ($3.10) and -37.6% vs its 200-day average ($4.29).
- 52-week range $2.61–$7.95; today's close sits at 1% of that range, 66.3% below the 52-week high.
Oct 2, 2026 — NAGE jumps 4.1% to $2.79 on 2.9x normal volume
- Closed at $2.79, +4.10% vs the prior close of $2.68. Day range $2.61–$2.80, opened at $2.72.
- Volume was 1.57M shares, 2.9x its 50-day average of 539.87K — unusually heavy trading.
- Price is -10.2% vs its 50-day average ($3.11) and -35.3% vs its 200-day average ($4.31).
- 52-week range $2.61–$8.07; today's close sits at 3% of that range, 65.4% below the 52-week high.
NAGE latest news & SEC filings
Every SEC filing by or about NAGE in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 4, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $29.79M (prior year $31.12M) (-4.3% vs Jun 30, 2025)
- Net income: $963.00K (prior year $3.61M) (-73.3% vs Jun 30, 2025)
- Diluted EPS: $0.01 (prior year $0.04) (-75.0% vs Jun 30, 2025)
Aug 4, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 29, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 10, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jul 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Jun 29, 2026 · Form S-3 — Shelf registration (S-3)
Shelf registration (S-3) — lets the company sell securities over time
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jun 26, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 26, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 26, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade NAGE
- Last results release: Aug 4, 2026 (8-K Item 2.02). Previous ones: May 6, 2026, Mar 4, 2026, Nov 4, 2025. Based on that rhythm, the next report is likely around Nov 3, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.24% (largest 8.2%).
- Liquidity: about 561.71K shares (≈$1.40M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $2.49 vs a range of $2.46–$7.95 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 8 open-market buys, 0 sales; latest: Ozan Pamir bought 4,465 shares on Nov 14, 2025.
- Latest filings: 10-Q Aug 4, 2026; 8-K Aug 4, 2026; 8-K Jun 29, 2026.
- Share count: 79.13M shares outstanding (Jul 30, 2026), -0.8% vs a year earlier.
- Listing: Nasdaq · industry: Medicinal Chemicals & Botanical Products.
NAGE market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 2.58 | 2.59 | 2.46 | 2.49 | 555.77K |
| Oct 15, 2026 | 2.55 | 2.60 | 2.53 | 2.58 | 444.20K |
| Oct 14, 2026 | 2.55 | 2.59 | 2.51 | 2.53 | 522.90K |
| Oct 13, 2026 | 2.63 | 2.64 | 2.55 | 2.58 | 636.50K |
| Oct 12, 2026 | 2.67 | 2.68 | 2.60 | 2.63 | 407.80K |
| Oct 9, 2026 | 2.68 | 2.71 | 2.67 | 2.69 | 268.10K |
| Oct 8, 2026 | 2.71 | 2.71 | 2.61 | 2.66 | 635.10K |
| Oct 7, 2026 | 2.67 | 2.76 | 2.65 | 2.72 | 361.10K |
| Oct 6, 2026 | 2.67 | 2.71 | 2.66 | 2.69 | 373.20K |
| Oct 5, 2026 | 2.79 | 2.79 | 2.67 | 2.68 | 864.80K |
| Oct 2, 2026 | 2.72 | 2.80 | 2.61 | 2.79 | 1.57M |
| Oct 1, 2026 | 2.91 | 2.92 | 2.67 | 2.68 | 1.39M |
| Sep 30, 2026 | 2.97 | 2.98 | 2.91 | 2.92 | 360.50K |
| Sep 29, 2026 | 3.00 | 3.00 | 2.95 | 2.95 | 279.10K |
| Sep 28, 2026 | 3.04 | 3.07 | 2.94 | 2.98 | 411.40K |
| Sep 25, 2026 | 3.02 | 3.06 | 2.98 | 3.05 | 618.90K |
| Sep 24, 2026 | 2.99 | 3.04 | 2.98 | 3.01 | 381.70K |
| Sep 23, 2026 | 3.08 | 3.09 | 3.00 | 3.00 | 390.90K |
| Sep 22, 2026 | 3.08 | 3.12 | 3.04 | 3.09 | 476.80K |
| Sep 21, 2026 | 2.99 | 3.04 | 2.97 | 3.04 | 292.10K |
About Niagen Bioscience
Niagen Bioscience (NAGE) is listed on the Nasdaq and classified by the SEC under “Medicinal Chemicals & Botanical Products”. Its business address is in LOS ANGELES, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1386570.
NAGE board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Ann Cohen | Director | Jun 26, 2026 |
| Robert N Fried | Chief Executive Officer | Jul 8, 2026 |
| Frank L Jr Jaksch | Director | Jun 26, 2026 |
| Wang Yu Gary Ng | Director | Jun 26, 2026 |
| Kristin Patrick | Director | Jun 26, 2026 |
| Steven D Rubin | Director | Jun 26, 2026 |
| Hamed Shahbazi | Director | Jun 26, 2026 |
| Wing Tak Wendy Yu | Director | Jun 26, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Robert N Fried | Chief Executive Officer | Jul 8, 2026 |
| Carlos Luis Lopez | SVP, General Counsel | Jul 8, 2026 |
| Ozan Pamir | Chief Financial Officer | Jul 8, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Nov 14, 2025 | Ozan Pamir | Buy | 4,465 | $6.81 |
| Nov 14, 2025 | Ozan Pamir | Buy | 2,220 | $6.85 |
| Nov 14, 2025 | Ozan Pamir | Buy | 4,465 | $6.81 |
| Nov 14, 2025 | Ozan Pamir | Buy | 2,220 | $6.85 |
| Nov 14, 2025 | Ozan Pamir | Buy | 4,465 | $6.81 |
| Nov 14, 2025 | Ozan Pamir | Buy | 2,220 | $6.85 |
| Nov 14, 2025 | Ozan Pamir | Buy | 4,465 | $6.81 |
| Nov 14, 2025 | Ozan Pamir | Buy | 2,220 | $6.85 |
NAGE financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $129.42M | $17.38M | 0.20 | $13.50M |
| Dec 31, 2024 | $99.60M | $8.55M | 0.11 | $12.11M |
| Dec 31, 2023 | $83.57M | $-4.94M | -0.07 | $7.12M |
| Dec 31, 2022 | $72.05M | $-16.54M | -0.24 | $-15.10M |
| Dec 31, 2021 | $67.45M | $-27.13M | -0.40 | $-24.16M |
Latest balance sheet: total assets $106.59M, total liabilities $24.06M, cash $64.10M (as of Jun 30, 2026).
NAGE earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 4, 2026 | 8-K Item 2.02 (results) | $3.47 |
| May 6, 2026 | 8-K Item 2.02 (results) | $4.97 |
| Mar 4, 2026 | 8-K Item 2.02 (results) | $4.94 |
| Nov 4, 2025 | 8-K Item 2.02 (results) | $6.95 |
| Aug 6, 2025 | 8-K Item 2.02 (results) | $9.40 |
| May 7, 2025 | 8-K Item 2.02 (results) | $8.45 |
| Mar 4, 2025 | 8-K Item 2.02 (results) | $5.60 |
| Oct 31, 2024 | 8-K Item 2.02 (results) | $3.49 |
| Aug 7, 2024 | 8-K Item 2.02 (results) | — |
| May 8, 2024 | 8-K Item 2.02 (results) | — |
| Mar 6, 2024 | 8-K Item 2.02 (results) | — |
| Nov 8, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Medicinal Chemicals & Botanical Products
Definium Therapeutics (DFTX)Trulieve Cannabis (TRLV)Tilray Brands (TLRY)IM Cannabis (IMCC)Glass House Brands (GLAS)Aurora Cannabis (ACB)Cronos (CRON)Usana Health Sciences (USNA)Regencell Bioscience (RGC)Canopy Growth (CGC)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on NAGE
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.